articleTop 1% cited
Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer – A randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
European Journal of Cancer · 2011 · Vol. 47(15) · pp. 2306–2314
Peter Thuss‐Patience✉(Charité - Universitätsmedizin Berlin)Albrecht Kretzschmar(Helios Hospital Berlin-Buch)Dmitry BichevT. Deist(Institut für Bodenkultur und Pflanzenbau)Axel HinkeKirstin BreithauptYasemin DoğanBernhard Gebauer(Charité - Universitätsmedizin Berlin)Guido Schumacher(Charité - Universitätsmedizin Berlin)Peter Reichardt
Gastric Cancer Management and OutcomesMetastasis and carcinoma case studiesGastrointestinal Tumor Research and TreatmentIrinotecanMedicineChemotherapyCancerPhases of clinical researchInternal medicineOncologyOxaliplatinSurgeryColorectal cancer
MeSH terms
Time FactorsSurvival AnalysisTreatment OutcomeIrinotecanAdenocarcinomaAdultAgedAntineoplastic Agents, PhytogenicCamptothecinFemaleGermanyHumansMaleMiddle AgedPalliative Care
Citations
611
FWCI
31.17
field-weighted impact
References
33
Percentile
100%
vs. same field & year
Citations per year
Cited by
Chemotherapy for advanced gastric cancer
Cochrane Database of Systematic Reviews · 2017 · 1,287 citations
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
The Lancet Oncology · 2014 · 2,435 citations
Advanced gastric cancer: Current treatment landscape and future perspectives
World Journal of Gastroenterology · 2016 · 577 citations
Treatment of gastric cancer
World Journal of Gastroenterology · 2014 · 626 citations
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2010 · 1,305 citations
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2016 · 1,581 citations
References
Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer
British Journal of Cancer · 1995 · 794 citations
Global cancer statistics
CA A Cancer Journal for Clinicians · 2011 · 55,006 citations
Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer
Annals of Oncology · 1997 · 858 citations
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
Journal of Clinical Oncology · 2006 · 3,448 citations
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
The Lancet Oncology · 2008 · 1,863 citations
Global cancer statistics
CA A Cancer Journal for Clinicians · 1999 · 3,420 citations
Nonparametric Estimation from Incomplete Observations
Journal of the American Statistical Association · 1958 · 38,793 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.